Hosted on MSN

Brookline Reaffirms Price Target for Moderna (MRNA) After Strong mRNA-1283 Vaccine Results

Moderna, Inc. (NASDAQ:MRNA) ranks among the best biotech stocks to buy. Following solid trial results for Moderna, Inc. (NASDAQ:MRNA)’s refrigerator-stable COVID-19 vaccine, Brookline Capital Markets ...
Hosted on MSN

Moderna reiterates 10% revenue-growth target as Covid vaccine demand falls

Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% revenue growth in 2026 following the launch of its next-generation Covid vaccine ...
Yahoo

FDA reverses course and will review Moderna’s mRNA-based flu shot

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu ...

Here's what you need to know about cancer vaccine development

Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...
WTKR

Fauci: It's 'possible, even likely' that Moderna booster won't be approved by Sept. 20 target date

Dr. Anthony Fauci on Tuesday said that there's a chance that Moderna's COVID-19 booster shot may not have FDA and CDC approval by the White House's Sept. 20 target date, though he expects that ...